Pathway analysis showed that ApoA1 serves as a hub protein connecting PPARs and NAFLD through a beneficial modulation of 16 out of 21 NAFLD upstream regulators [50]. The gene discussed is APOA1; the disease is metabolic dysfunction-associated steatotic liver disease.